Protective Mechanisms Of MAP Kinase Phosphatase 5 In Adipose Tissue Fibrosis, Hepatic Steatosis And Atherosclerosis
Funder
National Health and Medical Research Council
Funding Amount
$352,729.00
Summary
Obesity and associated complications such as diabetes, non-alcoholic fatty liver disease and atherosclerosis are a serious health burden. Recently, we found that MKP5, a molecule that restricts intracellular signaling, plays a central role in preventing these diseases. This collaborative project will elucidate how precisely MKP5 acts and explore how this molecule can be targeted for the development of novel therapeutic strategies in prevention and treatment of human metabolic diseases.
Impact Of Exercise Intervention On The Phenome (Metabolism And Predictive Complications) In Well Characterised Prediabetes And New Onset Type 2 Diabetes Cohorts In China And Australia (TheDiabeEx.JointStudy).
Funder
National Health and Medical Research Council
Funding Amount
$567,323.00
Summary
This proposal will study people with prediabetes or a new diagnosis of type 2 diabetes, compared with a group with normal blood glucose, in China and in Australia. It will examine, in well defined cohorts: 1. the extent of traditional and more novel organ complications and metabolic markers early in the disease course; 2. in people with abnormal blood glucose, the potential benefits of an exercise regimen to their metabolic health, biomarkers and complications.
Role Of Sphingolipid Signalling In Hepatic Insulin Resistance And Its Application In Prediction Of Risk For Type 2 Diabetes And Prediabetes
Funder
National Health and Medical Research Council
Funding Amount
$563,305.00
Summary
Type 2 diabetes is expected to reach epidemic proportions in the coming decades. Prediabetes is usually unrecognized and constitutes a major public health concern that needs earlier interventions, because the majority of prediabetic subjects proceed to T2D. We have identified an enzyme that plays an important role in insulin signalling. The possibility is that the level or activity of this enzyme is a potential biomarker of the prediabetes state and could be also used as a target
ACERH- Inovative Analyses Of Health Insurance, Ageing And The Economic Burden Of Illness And Injury
Funder
National Health and Medical Research Council
Funding Amount
$4,500,000.00
Summary
An inter-university collaborative research centre – the Australian Centre for Economic Research on Health (ACERH) – will be established, undertaking applied health economics research within three research programs: health insurance; ageing; and the economic analysis of illness and injury. ACERH will develop a unique, unit record, linked data set, including data from private health insurance partners, providing longitudinal data on health service utilisation in both public and private sectors.
ACTION - Aggression In Children: Unravelling Gene-environment Interplay To Inform Treatment
Funder
National Health and Medical Research Council
Funding Amount
$453,871.00
Summary
Aggression inflicts a huge personal, psychological and financial burden on affected individuals, their relatives, and society at large. ACTION will deliver an overarching framework that combines a thorough understanding of pathways leading to aggression with a map of current gaps, best practices on clinical, ethical, legal, and social issues.
DIREKT: Disarming The Intravascular Innate Immune Response To Improve Modalities For Chronic Kidney Disease Treatment
Funder
National Health and Medical Research Council
Funding Amount
$362,830.00
Summary
Dialysis is the mainstay treatment for patients with end-stage kidney disease while they await transplantation. However, the dialysis process causes inflammation in patients, affecting their health and longevity. This project aims to develop new bioreagents that can be applied to dialysis devices to reduce inflammation and thus improve patient outcomes. These bioreagents will also be used to modify donor kidneys so that they are protected from inflammation associated with transplantation.
OzENTER-TBI_Australia-Europe NeuroTrauma Effectiveness Research In TBI Collaboration
Funder
National Health and Medical Research Council
Funding Amount
$368,823.00
Summary
The OzENTER-TBI project will advance the care of traumatic brain injury (TBI) patients. Researchers will collaborate with the European CENTER-TBI project to characterise and classify TBI. They will contribute to large data sets which will explore the differences between sites and countries on TBI outcomes. They will also investigate emerging technologies in TBI. It will have a profound impact on treatment, health care costs and ultimately quality of life for TBI patients worldwide.